Articles - Polyplus®

Filter by

SARS-CoV-2 coronavirus (COVID-19) transfection research highlights

April 28, 2021(4 years)

Update on new viral vector strategies in gene therapy

February 25, 2021(4 years)

Optimization of AAV process development: transfection matters

January 26, 2021(4 years)

Promising non-viral vector for efficient and versatile delivery of mRNA for antigen-specific immunotherapy

January 11, 2021(4 years)

Viral vectors for gene therapy in a nutshell: AAVs, lentivirus, adenovirus and retrovirus

November 10, 2020(5 years)

Expression of recombinant proteins

October 27, 2020(5 years)

Transfection toolbox for spike protein vaccine strategies

June 3, 2020(5 years)

Are suspension-based systems for cell and gene therapy key to commercial-scale manufacture?

April 27, 2020(5 years)

Solving the viral vector bottleneck during a pandemic

April 21, 2020(5 years)

FectoVIR^®-AAV, a giant step for AAV large scale manufacturing

April 17, 2020(5 years)